1899:-
Uppskattad leveranstid 7-12 arbetsdagar
Fri frakt för medlemmar vid köp för minst 249:-
Andra format:
- Inbunden 3199:-
- Inbunden 3169:-
- Inbunden 3169:-
- Inbunden 4039:-
- Inbunden 4189:-
- Pocket/Paperback 2249:-
- Pocket/Paperback 2239:-
- Pocket/Paperback 2239:-
- Previously published in hardcover 2609:-
- Previously published in hardcover 2469:-
- Visa fler Visa färre
This translational book describes in detail the clinical application of novel approaches in cancer immunotherapy with the aim of educating clinicians in the implications of the most recent research and new developments in the field. The scope is broad, encompassing, for example, prognostic biomarkers for personalized cancer treatment, strategies for targeting tumor immunosuppression, gene therapy, virus-based vaccines, targeting of cancer stem cells, hematopoietic stem cell transplantation, the role of T lymphocytes in cancer immunotherapy, use of monoclonal antibodies, and many more innovative approaches. Clinical immunologists, hematologists, and oncologists in particular will find the book to be of value in expanding their knowledge. The book is the second in a three-volume series, Cancer Immunology, which offers an up-to-date review of cancer immunology and immunotherapy. The remaining volumes focus on the immunopathology of cancers and cancer immunotherapy for organ-specific tumors. In total the series, designed for both clinicians and researchers, includes contributions from more than 250 scientists working at leading universities and institutes from across the world.
- Format: Previously published in hardcover
- ISBN: 9783662513835
- Språk: Engelska
- Antal sidor: 485
- Utgivningsdatum: 2016-10-06
- Förlag: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG